Welcome to LookChem.com Sign In|Join Free

CAS

  • or
1-CBZ-2-PIPERIDINECARBOXYLIC ACID, also known as 1-(Phenylmethyl) Ester of 2-Piperidinedicarboxylic Acid, is an organic compound with a white solid appearance. It is characterized by its chemical structure, which includes a carboxylic acid group and a phenylmethyl ester group attached to a piperidine ring. 1-CBZ-2-PIPERIDINECARBOXYLIC ACID is known for its potential applications in the pharmaceutical industry, particularly in the development of therapeutic agents for various diseases.

28697-07-6 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 28697-07-6 Structure
  • Basic information

    1. Product Name: 1-CBZ-2-PIPERIDINECARBOXYLIC ACID
    2. Synonyms: 1-CBZ-PIPERIDINE-2-CARBOXYLIC ACID;1-CBZ-2-PIPERIDINECARBOXYLIC ACID;1-(CARBOBENZYLOXY)-2-PIPERIDINECARBOXYLIC ACID;1-(Carbobenzyloxy)-2-piperidinecarbozylicacid;1-N-Cbz-piperidine-2-carboxylic acid;N-CARBOBENZYLOXYPIPERIDINE-2-CARBOXYLIC ACID;N-CARBOBENZYLOXY-2-PIPERIDINECARBOXYLIC ACID;PIPERIDINE-1,2-DICARBOXYLIC ACID 1-BENZYL ESTER
    3. CAS NO:28697-07-6
    4. Molecular Formula: C14H17NO4
    5. Molecular Weight: 263.29
    6. EINECS: N/A
    7. Product Categories: Piperidine
    8. Mol File: 28697-07-6.mol
  • Chemical Properties

    1. Melting Point: 80-83℃
    2. Boiling Point: 443.922 °C at 760 mmHg
    3. Flash Point: 222.276 °C
    4. Appearance: /
    5. Density: 1.265 g/cm3
    6. Vapor Pressure: 1.16E-08mmHg at 25°C
    7. Refractive Index: N/A
    8. Storage Temp.: 2-8°C
    9. Solubility: N/A
    10. PKA: 4.01±0.20(Predicted)
    11. CAS DataBase Reference: 1-CBZ-2-PIPERIDINECARBOXYLIC ACID(CAS DataBase Reference)
    12. NIST Chemistry Reference: 1-CBZ-2-PIPERIDINECARBOXYLIC ACID(28697-07-6)
    13. EPA Substance Registry System: 1-CBZ-2-PIPERIDINECARBOXYLIC ACID(28697-07-6)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: 20/21/22
    3. Safety Statements: 24/25-36/37/38-29/56-41-45-3/7/9
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 28697-07-6(Hazardous Substances Data)

28697-07-6 Usage

Uses

Used in Pharmaceutical Industry:
1-CBZ-2-PIPERIDINECARBOXYLIC ACID is used as a key intermediate in the synthesis of disubstituted azetidinones, which are selective inhibitors of cysteine protease cathepsin K. These inhibitors play a crucial role in the treatment of various diseases, such as osteoporosis and other bone-related disorders, by targeting the enzyme responsible for bone resorption.
1-CBZ-2-PIPERIDINECARBOXYLIC ACID is also used in the synthesis of 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888), a potent Poly(ADP-ribose) Polymerase (PARP) inhibitor. PARP inhibitors are a class of drugs that have shown promise in the treatment of various types of cancer, including breast, ovarian, and pancreatic cancers. They work by exploiting the DNA repair deficiencies in cancer cells, leading to their selective destruction while sparing healthy cells.

Check Digit Verification of cas no

The CAS Registry Mumber 28697-07-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,8,6,9 and 7 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 28697-07:
(7*2)+(6*8)+(5*6)+(4*9)+(3*7)+(2*0)+(1*7)=156
156 % 10 = 6
So 28697-07-6 is a valid CAS Registry Number.
InChI:InChI=1/C14H17NO4/c16-13(17)12-8-4-5-9-15(12)14(18)19-10-11-6-2-1-3-7-11/h1-3,6-7,12H,4-5,8-10H2,(H,16,17)/p-1/t12-/m0/s1

28697-07-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-CBZ-2-PIPERIDINECARBOXYLIC ACID

1.2 Other means of identification

Product number -
Other names 1-CBZ-PIPERIDINE-2-CARBOXYLIC ACID

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:28697-07-6 SDS

28697-07-6Relevant articles and documents

A short enantioselective synthesis of pipecolic acid

Fernandez-Garcia,McKervey

, p. 2905 - 2906 (1995)

A simple enantioselective route to pipecolic acid is described. The key step involves the Sharpless asymmetric epoxidation of an N-protected aminoheptenol which spontaneously cyclises to a piperidine derivative on deprotection.

TUBULYSIN DERIVATIVES AND METHODS FOR PREPARING THE SAME

-

Page/Page column 29, (2020/02/16)

The invention relates to novel means and methods for the synthesis of tubulysin and derivatives thereof, which find their use e.g. as cytotoxic agents in targeted drug delivery. Provided is a method for preparing a tubulysin derivative, comprising reacting compounds A, B and C in a 3- component Passerini reaction, wherein compound A is a carboxylic acid according to the general formula (A); wherein compound B is an aldehyde according to the general formula (B); and wherein compound C is an isocyanide according to the general formula (C).

Pipecolic esters as minimized templates for proteasome inhibition

Giletto, Matthew B.,Osmulski, Pawel A.,Jones, Corey L.,Gaczynska, Maria E.,Tepe, Jetze J.

, p. 2734 - 2746 (2019/03/12)

Allosteric regulators of clinically important enzymes are gaining popularity as alternatives to competitive inhibitors. This is also the case for the proteasome, a major intracellular protease and a target of anti-cancer drugs. All clinically used proteasome inhibitors bind to the active sites in catalytic chamber and display a competitive mechanism. Unfortunately, inevitable resistance associated with this type of inhibition drives the search for non-competitive agents. The multisubunit and multicatalytic “proteolytic machine” such as the proteasome is occasionally found to be affected by agents with other primary targets. For example the immunosuppressive agent rapamycin has been shown to allosterically inhibit the proteasome albeit at levels far higher than its mTOR related efficacy. As part of an ongoing program to search for novel proteasome-targeting pharmacophores, we identified the binding domain of rapamycin as required for proteasome inhibition even without the macrocyclic context of the parent compound. By subsequent structure-activity relationship studies, we generated a pipecolic ester derivative compound 3 representing a new class of proteasome inhibitors. Compound 3 affects the core proteasome activities and proliferation of cancer cells with low micromolar/high nanomolar efficacy. Molecular modeling, atomic force microscopy imaging and biochemical data suggest that compound 3 binds into one of intersubunit pockets in the proteasomal α ring and destabilizes the α face and the gate. The α face is used as a docking area for proteasome-regulating protein modules and the gate is critical for controlling access to the catalytic chamber. Thus, the pipecolic ester template elicits a new and attractive mechanism for proteasome inhibition distinct from classical competitive drugs.

PIPECOLIC ESTERS FOR INHIBITION OF THE PROTEASOME

-

Paragraph 00274; 00276, (2019/08/26)

The present disclosure relates to chemical compounds that modulate proteasome activity, pharmaceutical compositions containing such compounds, and use of these compounds and compositions for the treatment of disorders of uncontrolled cellular proliferation such as, for example, a cancer. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

PROCESS FOR THE PRODUCTION OF COBIMETINIB

-

Page/Page column 33, (2019/05/22)

The present invention relates to a novel route of synthesis for the production of enantiomerically pure Cobimetinib, new intermediates in the synthesis of Cobimetinib and an amorphous Cobimetinib hemifumarate salt comprising a high salt content.

Synthesis method of bupivacaine

-

Paragraph 0010; 0015, (2016/10/10)

The invention belongs to a synthesis method of bupivacaine. The method comprises: adding 2 piperidinecarboxylicacid into aqueous alkali, dropwise adding Cbz and alkaline water, after finishing dropwise adding at normal temperature, reacting for 12 hours, after reaction, extracting with diethyl ether, washing a water layer to be weak-acid with 18% of diluted hydrochloric acid, extracting with the diethyl ether again, combining an diethyl ether layer, drying and filtering, and concentrating to obtain a dried product; adding the dried product into a DMF solvent, then adding a catalyst for reaction for 1 hour at normal temperature, then adding 2,6-dimethylaniline, reacting for 18hours at normal temperature, adding water and ethyl acetate for washing, taking an organic layer, drying and filtering, and concentrating to obtain a dried concentrated product; adding the dried concentrated product into a solvent, then adding a catalyst, pressurizing and introducing hydrogen, filtering after reaction and concentrating to obtain a dried product; adding the product in the above step into a solvent, dropwise adding bromo-n-butane at normal temperature, after dropwise adding, rising temperature to 80 DEG C for reacting for 12 hours, adding diluted hydrochloric acid, slowing cooling to normal temperature, and crystallizing, filtering and drying to obtain the product. The synthesis method has the advantages of higher yield, smaller pollution and low equipment requirement.

Ring-Strain Effects in Base-Induced Sommelet–Hauser Rearrangement: Application to Successive Stereocontrolled Transformations

Tayama, Eiji,Watanabe, Kazutoshi,Matano, Yoshihiro

supporting information, p. 3631 - 3641 (2016/07/29)

The base-induced Sommelet–Hauser (S–H) rearrangement of azetidine-2-carboxylic acid ester-derived ammonium salts into 2-aryl-substituted derivatives was demonstrated. The ring-strain of four-membered N-heterocycles enables efficient generation of the desired ylide intermediate and enhances the rate of the S–H rearrangement. The asymmetric version of the rearrangement was characterized by excellent levels of successive chirality transmissions. The regio- and stereo-controlled nucleophilic ring opening of the rearrangement products produced quaternary α-aryl amino acid esters with excellent enantiopurities.

A short enantioselective total synthesis of (R)- and (S)-pipecolic acid

Chavan, Subhash P.,Khairnar, Lalit B.,Chavan, Prakash N.,Kalbhor, Dinesh B.

, p. 1246 - 1251 (2015/02/19)

A convenient and practical total synthesis of (R)- and (S)-pipecolic acid has been achieved by utilizing chiral cis-aziridine-2-carboxylate as the common synthetic precursor. The synthesis involves regioselective reductive cleavage of the aziridine ring and Wittig olefination as key reactions.

CONDENSED HETEROCYCLIC COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY

-

Page/Page column 106, (2010/04/03)

The present disclosure provides compounds having affinity for the 5-HT6 receptor which are of the formula (I) wherein R1, A, B, D, E, G, Q, Ar, n, m, and p are as defined herein. The disclosure also relates to methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.

Formation of N-acyl-N,N'-dicyclohexylureas from DCC and arenecarboxylic acids in the presence of hydroxybenzotriazole in CH2CI2 at room temperature

Kaiser, Carlos R.,Pinheiro, Alessandra C.,De Souza, Marcus V. N.,Wardell, James L.,Wardell, Solange M.S.V.

experimental part, p. 468 - 472 (2009/08/15)

The syntheses of N-acyl-N',N'-dicyclohexylureas from 1,3- dicyclohexylcarbodiimide and arenecarboxylic acids [p-XC6H 4CO2H (X = H or NO2), 2-, 3- or 4-pyridinecarboxylic acid and pyrazinecarboxylic acid] in the

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 28697-07-6